Trademarkia Logo

Canada

C$
BIOTEST & DESIGN
REGISTERED

on 2 Jun 2005

Last Applicant/ Owned by

BIOTEST AG A GERMAN COMPANY

Landsteinerstrasse 5 63303 Dreieich

DE

Serial Number

1151903 filed on 6th Sept 2002

Registration Number

TMA641177 registered on 2th Jun 2005

Registration expiry Date

2th Jun 2030

Correspondent Address

MACRAE & CO.

326 Somerset Street WestOttawa

ONTARIO

CA

K2P0J9

BIOTEST & DESIGN

Trademark usage description

pharmaceutical and veterinary preparations for the treatment of immunological diseases, namely, immunologic deficiency syndromes, autoimmune diseases; Read More

Vienna Information


1 . 13 . 1

Armillary spheres, planetaria, astronomic orbits, atomic models, molecular modelsSphères armillaires, planétariums, orbites astronomiques, schémas d'atomes, schémas de molécules

1 . 13 . 15

Atomic models, molecular models, representations of human, animal or vegetal cellsSchémas atomiques, schémas de molécules, représentations de cellules humaines, animales ou végétales

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 8

BlackNoir

Classification Information


Class [005]
Pharmaceutical and veterinary preparations for the treatment of immunological diseases, namely, immunologic deficiency syndromes, autoimmune diseases; pharmaceutical and veterinary preparations for the treatment of cancer, antivirals; pharmaceutical and veterinary preparations for the treatment of conditions of virus reactivation; pharmaceutical and veterinary preparations for the treatment of anemia, namely protein anemia, immune globulin anemia; pharmaceutical and veterinary preparations for the treatment of blood coagulation disorders, namely anticoagulants, coagulants and blood coagulation factors; immunosuppressants; food for babies; medical plasters; materials for wound, burn or surgical dressing; blood products, immune globulin preparations, globulin preparations, coagulation factors; medicines for influencing blood coagulation; immune globulin preparations for treating immune insufficiencies, especially autoimmune insufficiencies, cancer, virus infections, conditions of virus reactivation, anemia, protein anemia, immune globulin anemia, blood coagulation disorders, and deficiencies in blood coagulation factors, or for preventing rejections in transplantation medicine; serum preparations, namely serum proteins and solutions comprising the same for medical use; human albumin for medical use; blood products for medical use, namely blood plasma; blood substitutes; plasma substitutes and plasma expanders; vaccines for human use, especially on basis of immune globulins; blood coagulation preparations, especially coagulation factors for clinical and medical laboratory use; antibiotics; narcotics; medicines for treating the central nervous system namely encephalitis, epilepsy, Alzheimer's disease, Parkinson's disease; pharmaceutical preparations for the treatment of cardiovascular diseases; medicines for treating the respiratory system; medicines for treatment of urological diseases, and sexually transmitted diseases; pharmaceutical preparations for use in gastroenterology; hormones; vitamins; immunosuppressive, anti-inflammatory, and antiallergic, medicines for medical uses; pharmaceutical preparations for use in ophthalmology and otology; in-vivo and in-vitro diagnostic preparations for clinical or medical purposes and laboratory use; antibodies, namely mono- and polyclonal antibodies for use in in-vivo clinical and medical diagnostics and for patient therapy; in vitro diagnostic agents for medical purposes, especially for determination of proteins, such as antibodies, monoclonal antibodies or immune globulins, or for determinations of nucleic acids, for blood group diagnostics and antibody determination, tissue typing, cell diagnostics, microbiological diagnostics, determination of toxic compounds and sanitary and hygiene monitoring; test kits comprising ready to use nutrient media for microorganisms, especially bacteria, and reagents for medical and laboratory uses, especially for blood group diagnostics, antibody determination, tissue typing, cell diagnostics, microbiological diagnostics, determination of toxic substances; test kits comprising monoclonal and polyclonal antibodies and natural and recombinant antigens, for tests on serological and immune genetic basis, and reagents therefore for human and veterinary medical laboratory purposes; immunoassays such as ELISA's, consisting of reagents, sera, monoclonal and polyclonal antibodies, natural and recombinant antigens, and reagents therefore for human and veterinary medical laboratory purposes; diagnostic preparations for human or veterinary medical uses in the treatment of infections; media for bacteriological cultures, namely ready-touse culture media and nutrient media and ingredients thereof; measuring and surveying apparatus namely dipsticks, teststrips, and agar strips for determination and quantification of interesting substances, especially blood sugar, blood and respiratory alcohol, toxic substances, oxygen and blood constituents such as hemoglobin.


Classification kind code

11

Mark Details


Serial Number

1151903

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 8th Dec 2004
Advertised
Submitted for opposition 26
on 4th Nov 2004
Approved
Submitted for opposition 15
on 22nd Jun 2004
Correspondence Created
Submitted for opposition 15
on 5th Dec 2003
Correspondence Created
Submitted for opposition 15
on 17th Jul 2003
Correspondence Created
Submitted for opposition 20
on 19th Nov 2002
Examiner's First Report
Submitted for opposition 22
on 30th Oct 2002
Search Recorded
Submitted for opposition 31
on 27th Sept 2002
Formalized
Submitted for opposition 1
on 12th Sept 2002
Created
Submitted for opposition 30
on 6th Sept 2002
Filed